On October 24, 2026, the UK Cabinet Office published “Introducing the AI Biosecurity Lab,” announcing the AI Biosecurity Lab (AIBL) under a National AI Biosecurity Initiative. The government calls AIBL the world’s first dedicated AI biosecurity organisation. Funding is £100 million from the government, plus up to £200 million in company commitments from OpenAI and Anthropic—together up to about £300 million.
OpenAI will provide £100 million in compute and model credits and trusted access to its most capable relevant models through the Rosalind Biodefense programme. Anthropic will provide up to £100 million in model credits, trusted model access, and dedicated technical support. Those credits and access are for the lab’s work, not personal API allowances or everyday coding quotas. AIBL will also partner with Google DeepMind and UK AI–life-sciences company Basecamp Research on research collaborations and AI-for-science tools; DeepMind says it will look to provide trusted access to frontier Gemini and specialised science models, and Basecamp will contribute AI-biology models and expertise.
Early work centres on detecting emerging biological threats sooner and speeding vaccines, treatments, and other medical countermeasures. AIBL will run as an independent non-profit. The government says that, like the UK AI Security Institute (AISI), it is set up to attract technical talent and move with autonomy. It launches with UKHSA, APHA, Dstl, and the life-sciences sector under the national initiative, and will work with the MHRA on health emergencies and AI-designed medicines.
Related: OpenAI Tightens Isolation for Frontier Model Training.